Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Section 5: Patient Safety and Quality Assurance
5PSQ-122
PERIPHERIC INTRAVENOUS PERFUSION IN ANAESTHESIA: SECURING MEDICAL TREATMENT IS ALSO ABOUT THE PROPER USE OF MEDICAL DEVICES
5PSQ-121
QUALITY ASSESSMENT WITHIN FRENCH FIRE AND RESCUE SERVICES PHARMACIES IN THE NORTH OF FRANCE: DEVELOPMENT AND EVALUATION OF A SELF-ASSESSMENT TOOL
5PSQ-120
APPLICATION OF INTERNATIONAL GERIATRIC CRITERIA ACCORDING TO EAHP POLICY STATEMENT ON AN AGEING SOCIETY
5PSQ-119
A PRELIMINARY SURVEY ON DAILY DRUG INTAKE IN OLDER PATIENTS IN COMPLIANCE WITH EAHP POLICY STATEMENT ON AN AGEING SOCIETY
5PSQ-118
SURVEILLANCE AND MONITORING OF PATIENT FALLS IN A HOSPITAL SETTING BY THE HOSPITAL PHARMACIST: FOCUS ON PATIENT-RELATED RISK FACTORS AND DRUG THERAPY
5PSQ-117
PREVENTING MEDICATION ERRORS REGARDING HIGH-ALERT MEDICATION
5PSQ-116
ANALYSIS AND EVALUATION OF A RENAL FUNCTION-BASED DOSAGE ADJUSTMENT SYSTEM AT A UNIVERSITY HOSPITAL
5PSQ-115
"PATIENT EXPERIENCE" FOR IMPROVING PATIENT CLINICAL PATHWAYS IN AN ONCOLOGY DAY HOSPITAL
5PSQ-114
EVALUATION OF PHARMACEUTICAL INTERVENTIONS PERFORMED ON MEDICATION ERRORS DETECTED IN THE PRESCRIPTION
5PSQ-113
HOW TO SECURE MEDICATION SELF-MANAGEMENT IN HOSPITALISED POSTPARTUM WOMEN?
5PSQ-112
RISK ASSESSMENT OF ELEMENTAL IMPURTIES FOR MANUFACTURING THE DRUG SUBSTANCE (ICH Q3D)
5PSQ-111
EVALUATION OF THE FORM'S QUALITY OF MEDICAL PRESCRIPTIONS FROM PUBLIC HOSPITALS AND PRIVATE CLINICS
5PSQ-110
COMPUTERISED PHYSICIAN ORDER ENTRY SYSTEMS AND RELATED CLINICAL DECISION SUPPORT TOOLS IN INPATIENT CARE – BARRIERS OF COST-EFFECTIVENESS
5PSQ-109
ABSTRACT WITHDRAWN
5PSQ-108
PROCEDURE FOR PAEDIATRIC EMERGENCY AND RESULTS OF A SURVEY ON USE
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »
Follow Us